Upcoming Events
Search Result For "Drug development".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging in...
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking ...
International conference on Medical Health Science, Pharmacology & Bio Technology(ICMPB) is a prestigious event organized with a motivation to prov...
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches...
As drug developers continue to utilize the expedited FDA regulatory pathway available for CBD, alongside a growing interest in the therapeutic bene...
In light of Anavex's announcement of its first entire clinical gene pathway data in patients with Rett syndrome, coupled with Mission Therapeutics'...
The field of Hippo Pathway targeted drugs is seeing a surge of activity, with new clinical data being generated everyday and novel combinations bei...
Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors The complement community is shifting gear, with more companies t...
With recent accelerated approval wins, positive clinical trial readouts, progression through clinical pipelines and exciting mergers and acquisitio...
Molecular glue development continues to thrive, offering exciting opportunities to target previously undruggable proteins and treat a wide range of...
Join us for the International Conference on Medical and Pharmaceutical Science (ICMPS) 2025 is a premier event uniting global researchers practitio...
In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements ...
Loading More...
